In a Myc-driven mouse cancer model, disruption of the SEC protein downregulates Myc-dependent transcriptional programs in cancer cells, reducing ribosome biogenesis and slowing cancer progression.48 This suggests that small molecules targeting SEC can be used to treat Myc-induced cancer. This evidence concerns the gene MYC and cancer.